P2‐200: Three cases of apparent Vasogenic Edema (VE) from a phase 2 clinical trial of the gamma secretase Inhibitor BMS‐708163 in patients with mild‐to‐moderate AD-Reference-Cited by-同舟云学术

P2‐200: Three cases of apparent Vasogenic Edema (VE) from a phase 2 clinical trial of the gamma secretase Inhibitor BMS‐708163 in patients with mild‐to‐moderate AD

Published:2011-07 Issue:4S_Part_11 Volume:7 Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Sperling Reisa¹,Bronen Richard²,Greenberg Steven³,Sorensen A. Gregory⁴,Salloway Stephen⁵,Gass Achim⁶,Meadowcroft Mark⁷,Berman Robert⁷,Albright Charles⁷,Coric Vlad⁷,Feldman Howard⁷

Affiliation:

1. Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Massachussets General Hospital, Harvard Medical SchoolBostonMassachusettsUnited States

2. Yale University School of MedicineNew HavenConnecticutUnited States

3. Massachusetts General Hospital and Harvard Medical SchoolBostonMassachusettsUnited States

4. Massachusetts General HospitalBostonMassachusettsUnited States

5. Butler HospitalProvidenceRhode IslandUnited States

6. University Hospital Mannheim, University of HeidelbergGermanyMannheimGermany

7. Bristol‐Myers SquibbWallingfordConnecticutUnited States

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2011.05.1085

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis;Cellular and Molecular Life Sciences;2019-02-15

2. First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheimer’s disease;Alzheimer's Research & Therapy;2016-03-01

3. Vascular alterations in PDAPP mice after anti‐Aβ immunotherapy: Implications for amyloid‐related imaging abnormalities;Alzheimer's & Dementia;2013-04-15

4. MR Imaging Features of Amyloid-Related Imaging Abnormalities;American Journal of Neuroradiology;2013-04-11